Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany.
Assessment and rehabilitation of driver skills: subjective experiences of people with multiple sclerosis and health professionals.
Case Studies: LAAM, Naltrexone, Clozapine, and Nicorette
The CSF JCV antibody index for diagnosis of natalizumab-associated PML.
The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ): development of a shortened scale.
Role of adenosine in oligodendrocyte precursor maturation.
Understanding Tremor in Multiple Sclerosis: Prevalence, Pathological Anatomy, and Pharmacological and Surgical Approaches to Treatment.
Unilateral ankle dorsiflexor spasticity: an uncommon, disabling complication of transverse myelitis.
A randomized clinical trial of valacyclovir in multiple sclerosis.
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study.
Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?
The role of endogenous antiradical protective system in multiple sclerosis.
JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.
[Importance and treatment of spasticity in multiple sclerosis : Results of the MOVE 1 study].
Does a waist-worn ActiGraph accelerometer quantify community ambulation in persons with multiple sclerosis?
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain.
Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis.
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants.
Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt-mTOR axis in mice.
Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated Encephalomyelitis.
Cognitive but not affective theory of mind deficits in mild relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
248
249
250
251
252
253
254
255
256
…
next ›
last »